Synopsis:- The stock jumped over 5% after securing a ₹550 crore, 10-year PPP contract to set up an advanced radiology centre in Assam. The deal strengthens presence in public healthcare, while operations span 40 centres, 360 collection points, 35 cities, and serve 18+ lakh patients annually.
The shares of a prominent healthcare company gained up to 5.2 percent in today’s trading session after the company secured a Rs 550 crore, 10-year PPP project from Northeast Frontier Railway’s Central Hospital in Assam.
With a market capitalisation of Rs 668 crores, the shares of Chandan Healthcare Limited were trading at Rs 276.40 per share, increasing around 5.28 percent as compared to the previous closing price of Rs 262.55 apiece.
Significant Contract
The shares of Chandan Healthcare have seen positive movement after securing a Rs 550 crore, 10-year PPP project from Northeast Frontier Railway’s Central Hospital in Assam. The contract involves setting up, operating and maintaining an advanced radiology imaging diagnostic centre. This order strengthens the company’s presence in public healthcare infrastructure and supports improved access to high-end diagnostic services in a government hospital setting.
Financials
The company delivered a strong year-on-year performance, with revenue rising 24% to Rs 136 crore in Sep 2025. Profitability improved sharply, as net profit grew 54% to Rs 17 crore, indicating better cost control, improved margins, and healthier operational efficiency over the period.
Over the last one year, Chandan Healthcare Ltd showed steady improvement in operating efficiency. Operating margin (OPM) expanded from 18% in Sep 2024 to 21% in Sep 2025, driven by better cost control and operating leverage. Operating profit rose from Rs 20 crore to Rs 28 crore, indicating a healthier and more sustainable core performance.
Chandan Healthcare has built a strong diagnostic network with over 20 years of experience, a 1,300+ member team, and presence across 35 cities in 4 states. It operates 40 diagnostic centres and 360 collection centres, serving 18+ lakh patients annually, with NABH and NABL accreditations supporting quality and trust.
Chandan Healthcare has built a strong regional presence across North and Central India with a network of large, medium, and small centres supported by 360 collection points. Uttar Pradesh contributes around 71% of revenue, while Uttarakhand adds 29%, reflecting deep penetration in key regional healthcare markets.
Chandan Healthcare is a fast-growing diagnostic and healthcare services provider in India, offering pathology, radiology, and pharmacy solutions. With a strong regional presence across North and Central India, the company focuses on quality diagnostics, wide accessibility, and integrated healthcare delivery backed by an expanding network of centres.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post Healthcare jumps 4% after bagging ₹550 Cr contract for radiology diagnostic centre appeared first on Trade Brains.